+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha Synuclein"

Alpha Synuclein - Pipeline Review, H2 2019 - Product Thumbnail Image

Alpha Synuclein - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 126 Pages
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019 - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

  • Drug Pipelines
  • April 2019
  • 123 Pages
From
Alpha-Synuclein (alphaSyn or SNCA) Inhibitor -Pipeline Insight, 2019 - Product Thumbnail Image

Alpha-Synuclein (alphaSyn or SNCA) Inhibitor -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Alpha-Synuclein (alphaSyn or SNCA) Inhibitors - Pipeline Insights, 2017 - Product Thumbnail Image

Alpha-Synuclein (alphaSyn or SNCA) Inhibitors - Pipeline Insights, 2017

  • Drug Pipelines
  • January 2017
  • 60 Pages
From
2020 Progressive Supranuclear Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Progressive Supranuclear Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 82 Pages
From
2020 Multiple System Atrophy (MSA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Multiple System Atrophy (MSA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 78 Pages
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2019 - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 87 Pages
From
Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects - Product Thumbnail Image

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • Report
  • May 2019
  • 84 Pages
From
  • 8 Results (Page 1 of 1)
Loading Indicator
adroll